Determining Front-Line Therapeutic Strategy for Metastatic Clear Cell Renal Cell Carcinoma.

Zarrabi, Kevin K; Lanade, Oladimeji; Geynisman, Daniel M

Zarrabi, Kevin K; Lanade, Oladimeji; Geynisman, Daniel M.

Afiliação

Zarrabi KK; Sidney Kimmel Cancer Center, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Lanade O; Fox Chase Cancer Center, Department of Medical Oncology, Temple University Health System, Philadelphia, PA 19111, USA.
Geynisman DM; Fox Chase Cancer Center, Department of Medical Oncology, Temple University Health System, Philadelphia, PA 19111, USA.

Cancers (Basel) ; 14(19)2022 Sep 22.

Article em En | MEDLINE | ID: mdl-36230530

Palavras-chave

immunotherapy; renal cell carcinoma; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google